Drugs,SMILES,Molecular Formula,Molar Refractivity,Polarizability
Phenylacetic Acid,C1=CC=C(C=C1)CC(=O)O,C8H8O2,37.4,14.8
Alitretinoin,CC1=C(C(CCC1)(C)C)/C=C/C(=C\C=C\C(=C\C(=O)O)\C)/C,C20H28O2,95.5,37.9
Genistein,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,C15H10O5,69.9,27.7
Cytarabine,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,C9H13N3O5,52.6,20.9
Glycyrrhizin,C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O,C42H62O16,201.4,79.8
Methoxsalen,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,C12H8O4,56.6,22.4
Dexamethasone,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,C22H29FO5,100.2,39.7
Ethinyl Estradiol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,C20H24O2,86.3,34.2
Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,C17H14F3N3O2S,91.9,36.4
Doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,C27H29NO11,131.5,52.1
Letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C17H11N5,87.1,34.5
Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,C21H16ClF3N4O3,113.1,44.8
Etoposide,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,C29H32O13,140.1,55.5
Aminoglutethimide,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,C13H16N2O2,64.4,25.5
Podofilox,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O,C22H22O8,104.3,41.3
Vinblastine,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,C46H58N4O9,220.7,87.5
Vinorelbine,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,C45H54N4O8,214.2,84.9
Tamoxifen,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,C26H29NO,118.9,47.1
Topotecan,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,C23H23N3O5,112.7,44.7
Vincristine,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,C46H56N4O10,221.1,87.6
Mitomycin,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N,C15H18N4O5,80.8,32
Melphalan,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,C13H18Cl2N2O2,78.8,31.2
Dactinomycin,C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C,C62H86N12O16,323.7,128.3
Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,C20H22N8O5,119,47.2
Azacitidine,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,C8H12N4O5,51.1,20.3
Fulvestrant,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,C32H47F5O3S,154,61.1
Fluorouracil,C1=C(C(=O)NC(=O)N1)F,C4H3FN2O2,25.9,10.2
Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,C5H4N4S,41,16.2
Gemcitabine,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,C9H11F2N3O4,52.1,20.6
Docetaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,C43H53NO14,205.2,81.4
Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,C33H38N4O6,159.2,63.1
7-Ethyl-10-hydroxycamptothecin,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O,C22H20N2O5,104.2,41.3
Acitretin,CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C)C)C)OC,C21H26O3,101.8,40.4
Mitotane,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,C14H10Cl4,79.7,31.6
Floxuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O,C9H11FN2O5,51.9,20.6
Paclitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,C47H51NO14,219.3,86.9
Disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,C10H20N2S4,86.4,34.2
Colchicine,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,C22H25NO6,106.6,42.3
Digoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,C41H64O14,196.4,77.9
Gossypol,CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O,C30H30O8,149.3,59.2
Phenylbutyric acid,C1=CC=C(C=C1)CCCC(=O)O,C10H12O2,46.6,18.5
Albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,C12H15N3O2S,72.7,28.8
Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,C18H20FN3O4,91.1,36.1
Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,C18H19N3O3S,98.1,38.9
Azelaic Acid,C(CCCC(=O)O)CCCC(=O)O,C9H16O4,46.9,18.6
Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,C16H18FN3O3,80.7,32
Mebendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,C16H13N3O3,82.4,32.7
Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,C17H18FN3O3,83.3,33
Nalidixic Acid,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,C12H12N2O3,60.1,23.8
Prednisolone,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,C21H28O5,95.5,37.9
Diethylstilbestrol,CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O,C18H20O2,83.2,33
Calcitriol,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,C27H44O3,124.4,49.3
Urethane,CCOC(=O)N,C3H7NO2,21.3,8.4
Noscapine,CN1CCC2=CC3=C(C(=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3,C22H23NO7,106.5,42.2
Flumequine,CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2)F)C(=O)O,C14H12FNO3,65.1,25.8
Curcumin,COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O,C21H20O6,104,41.2
Cinnamaldehyde,C1=CC=C(C=C1)/C=C/C=O,C9H8O,42.3,16.8
Carbendazim,COC(=O)NC1=NC2=CC=CC=C2N1,C9H9N3O2,52.6,20.9
Psoralen,C1=CC(=O)OC2=CC3=C(C=CO3)C=C21,C11H6O3,49.9,19.8
Sirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,C51H79NO13,246.7,97.8
Tetrandrine,CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC,C38H42N2O6,178.1,70.6
Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,C21H23N7O2S,120.2,47.6
Daunorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,C27H29NO10,130,51.5
Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,C29H26ClFN4O4S,152.5,60.4
Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,C22H27FN4O2,112.5,44.6
Mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,C22H8N4O6,119.7,47.5
Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,C22H23N3O4,110.1,43.6
Omacetaxine Mepesuccinate,CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O,C29H39NO9,140.6,55.7
Teniposide,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@H](O7)C8=CC=CS8)O)O,C32H32O13S,158.3,62.8
Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,C22H24ClFN4O3,118.8,47.1
Cladribine,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,C10H12ClN5O3,63.7,25.3
Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,C23H18ClF2N3O3S,121.6,48.2
Testolactone,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC(=O)O2)CCC4=CC(=O)C=C[C@]34C,C19H24O3,83.4,33
Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C14H19Cl2NO2,79.9,31.7
Bortezomib,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,C19H25BN4O4,103,40.8
Ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,C26H28Cl2N4O4,139.1,55.2
Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C14H20N2O3,73.5,29.1
17alpha-Estradiol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@H]2O)CCC4=C3C=CC(=C4)O,C18H24O2,79.5,31.5
Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C13H10N2O4,65.2,25.9
Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,C19H14Cl2N2O3S,105.5,41.8
Vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,C22H24BrFN4O2,120,47.6
Hydroxyurea,C(=O)(N)NO,CH4N2O2,13.8,5.5
Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,C13H11N3O4,66.6,26.4
Amsacrine,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,C21H19N3O3S,111.5,44.2
Thioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,C5H5N5S,41.9,16.6
2-Methoxyestradiol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=C(C=C34)OC)O,C19H26O3,86.2,34.2
Pentostatin,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O,C11H16N4O4,62.7,24.8
Retinyl acetate,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/COC(=O)C)/C)/C,C22H32O2,105,41.6
Pipobroman,C1CN(CCN1C(=O)CCBr)C(=O)CCBr,C10H16Br2N2O2,68.7,27.2
Raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,C28H27NO4S,136.6,54.1
Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],C9H7N7O2S,68.9,27.3
Aminolevulinic Acid,C(CC(=O)O)C(=O)CN,C5H9NO3,30.3,12
Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,C18H14F4N2O4S,93.8,37.2
Mitomycin A,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)OC,C16H19N3O6,83.5,33.1
Streptozocin,CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,C8H15N3O7,53.2,21.1
Etretinate,CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C,C23H30O3,111.3,44.1
N-Methylformamide,CNC=O,C2H5NO,15.1,6
Mycophenolic Acid,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O,C17H20O6,83.1,32.9
Cyproterone acetate,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C,C27H29ClO4,109.2,43.3
6-Azauridine,C1=NN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,C8H11N3O6,50,19.8
Enclomiphene,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3,C26H28ClNO,123.7,49.1
Asiatic Acid,C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O,C30H48O5,136.6,54.1
Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,C21H30O2,97,38.5
P-Toluenesulfonamide,CC1=CC=C(C=C1)S(=O)(=O)N,C7H9NO2S,43.8,17.4
cyclosporin A,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,C62H111N11O12,328.8,130.4
Prednisone,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,C21H26O5,94.1,37.3
Tacrolimus,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,C44H69NO12,214.1,84.9
Moxifloxacin,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,C21H24FN3O4,101.8,40.4
Methyltestosterone,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C,C20H30O2,87.8,34.8
Oxolinic Acid,CCN1C=C(C(=O)C2=CC3=C(C=C21)OCO3)C(=O)O,C13H11NO5,63.3,25.1
Quinacrine,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,C23H30ClN3O,122,48.3
Medroxyprogesterone,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,C22H32O3,97.1,38.5
Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,C19H33NO2,93.6,37.1
Fisetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O)O)O,C15H10O6,71.4,28.3
Clioquinol,C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1,C9H5ClINO,61.9,24.5
Idoxuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O,C9H11IN2O5,64.8,25.7
Mequinol,COC1=CC=C(C=C1)O,C7H8O2,34.8,13.8
Vincamine,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4[C@](C2)(C(=O)OC)O,C21H26N2O3,98.3,39
Penicillamine,CC(C)([C@H](C(=O)O)N)S,C5H11NO2S,38.1,15.1
Acadesine,C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N)C(=O)N,C9H14N4O5,54.6,21.6
Artesunate,C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)O)C,C19H28O8,92.2,36.6
Phorbol 12-myristate 13-acetate,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,C36H56O8,168.3,66.7
Hypoxanthine,C1=NC2=C(N1)C(=O)NC=N2,C5H4N4O,34.7,13.8
Oxalacetic acid,C(C(=O)C(=O)O)C(=O)O,C4H4O8,23.7,9.4
Benomyl,CCCCNC(=O)N1C2=CC=CC=C2N=C1NC(=O)OC,C14H18N4O3,77.8,30.8
"Carvone, (+/-)-",CC1=CCC(CC1=O)C(=C)C,C10H14O,45.5,18
Oleandrin,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(C[C@@H]([C@@H]5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)O,C32H48O9,149.5,59.3
Musk ketone,CC1=C(C(=C(C(=C1[N+](=O)[O-])C(C)(C)C)[N+](=O)[O-])C)C(=O)C,C14H18N2O5,77.4,30.7
Phenethyl isothiocyanate,C1=CC=C(C=C1)CCN=C=S,C9H9NS,51.9,20.6
Diacetoxyscirpenol,CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H]([C@H]([C@H]([C@@]34CO4)O2)O)OC(=O)C)C)COC(=O)C,C19H26O7,90.2,35.8
Aminopterin,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N,C19H20N8O5,114.3,45.3
Megestrol Acetate,CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,C19H26O7,106.4,42.2
Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,C29H27F3N6O,145.1,57.5
Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C29H31N7O,147.1,58.3
Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,C22H18N4OS,113.5,45
Exemestane,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,C20H24O2,85.8,34
Anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,C17H19N5,90,35.7
Citomid,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,C46H56N4O10,221.1,87.6
Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,C22H26ClN7O2S,132,52.3
Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,C28H22F3N7O,141.8,56.2
Crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,C21H22Cl2FN5O,114.4,45.4
Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,C24H28O2,107.4,42.6
Idelalisib,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,C22H18FN7O,114,45.2
Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,C26H29Cl2N5O3,141.9,56.3
Everolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,C53H83NO14,257.7,102.2
Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,C21H15ClF4N4O3,113.1,44.8
Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,C30H29ClN6O3,155.1,61.5
Romidepsin,C/C=C\1/C(=O)N[C@H](C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C,C24H36N4O6S2,142,56.3
Raltitrexed,CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N1,C21H22N4O6S,117.4,46.5
Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C13H13N3O3,66.5,26.3
Fludarabine,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,C10H12FN5O4,59.8,23.7
Camptothecin,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,C20H16N2O4,93.4,37
Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,C15H22FN3O6,82.3,32.6
Clofarabine,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N,C10H11ClFN5O3,63.6,25.2
Tegafur,C1CC(OC1)N2C=C(C(=O)NC2=O)F,C8H9FN2O3,44.3,17.6
Tofacitinib,C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,C16H20N6O,87.5,34.7
Clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,C26H28ClNO,123.7,49.1
Trabectedin,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,C39H43N3O11S,195.7,77.6
Leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,C12H9F3N2O2,61,24.2
Eflornithine,C(CC(C(F)F)(C(=O)O)N)CN,C6H12F2N2O2,38.7,15.4
Afimoxifene,CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,C26H29NO2,120.8,47.9
Vinpocetine,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC,C22H26N2O2,101.5,40.2
Uracil Mustard,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,C8H11Cl2N3O2,57.8,22.9
Nelarabine,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,C11H15N5O5,65.8,26.1
5-Bromo-2’-deoxyuridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Br)CO)O,C9H11BrN2O5,58.9,23.4
Trichlormethine,C(CCl)N(CCCl)CCCl,C6H12Cl3N,48.1,19.1
Tazarotene,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,C21H21NO2S,101.4,40.2
Ursolic Acid,C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O,C30H48O3,133.5,52.9
Pralatrexate,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,C23H23N7O5,125.9,49.9
Plicamycin,C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@@H]2C[C@@H](O[C@@H]([C@H]2O)C)OC3=CC4=CC5=C(C(=O)[C@H]([C@@H](C5)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O)O[C@H]7C[C@H]([C@H]([C@H](O7)C)O)O[C@H]8C[C@]([C@@H]([C@H](O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,C52H76O24,262.3,104
Demecolcine,CN[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,C21H25NO5,101.9,40.4
Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,C11H11F3N2O3,61.3,24.3
Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,C12H11NO,55.1,21.8
Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,C11H16N4O4,63.1,25
Cabazitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,C45H57NO14,214.9,85.2
Masoprocol,C[C@H](CC1=CC(=C(C=C1)O)O)[C@@H](C)CC2=CC(=C(C=C2)O)O,C18H22O4,86.3,34.2
Epothilone B,C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C,C27H41NO6S,138.4,54.9
Trimetrexate,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC,C19H23N5O3,107.7,42.7
Plumbagin,CC1=CC(=O)C2=C(C1=O)C=CC=C2O,C11H8O3,49.5,19.6
Cordycepin,C1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C(N=CN=C32)N)CO,C10H13N5O3,59.1,23.4
Ingenol Mebutate,C/C=C(/C)\C(=O)O[C@H]1C(=C[C@@]23[C@@]1([C@@H](C(=C[C@H](C2=O)[C@H]4[C@H](C4(C)C)C[C@H]3C)CO)O)O)C,C25H34O6,115.2,45.6
Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,C17H14O4S,82.7,32.8
Amifostine,C(CN)CNCCSP(=O)(O)O,C5H15N2O3PS,50.3,19.9
Sulindac,CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,C20H17FO3S,96.2,38.1
Mycophenolate Mofetil,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O,C23H31NO7,114.2,45.3
3-Aminobenzamide,C1=CC(=CC(=C1)N)C(=O)N,C7H8N2O,39.4,15.6
Indirubin,C1=CC=C2C(=C1)C(=C(N2)O)C3=NC4=CC=CC=C4C3=O,C16H10N2O2,72.2,28.6
Gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,C19H22FN3O4,94.6,37.5
Ubenimex,CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)N)O,C16H24N2O4,83,32.9
Enoxacin,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,C15H17FN4O3,78.8,31.2
Triptolide,CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@H]5C[C@H]7[C@]4([C@@H]2O)O7)COC6=O)C,C20H24O6,88.3,35
Tibolone,C[C@@H]1CC2=C(CCC(=O)C2)[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C#C)O,C21H28O2,90,35.7
Epigallocatechin Gallate,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,C22H18O11,108.4,43
Silybin,COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,C25H22O10,120,47.6
Medroxyprogesterone acetate,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C,C24H34O4,106.7,42.3
Sulforaphane,CS(=O)CCCCN=C=S,C6H11NOS2,49.2,19.5
Indole-3-Carbinol,C1=CC=C2C(=C1)C(=CN2)CO,C9H9NO,45,17.8
Sinomenine,CN1CC[C@@]23CC(=O)C(=C[C@@H]2[C@@H]1CC4=C3C(=C(C=C4)OC)O)OC,C19H23NO4,89.5,35.5
Methyl Methanesulfonate,COS(=O)(=O)C,C2H6O3S,21.9,8.7
Lycopene,CC(=CCC/C(=C/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C=C(/CCC=C(C)C)\C)\C)\C)/C)/C)/C)C,C40H56,186.9,74.1
Diallyl sulfide,C=CCSCC=C,C6H10S,37.3,14.8
Perillyl alcohol,CC(=C)C1CCC(=CC1)CO,C10H16O,46.9,18.6
Bryostatin 1,CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)/C[C@H]2C[C@@H](OC(=O)C[C@@H](C[C@@H]3C[C@@H](C([C@@](O3)(C[C@@H]4C/C(=C/C(=O)OC)/C[C@@H](O4)/C=C/C([C@@]1(O2)O)(C)C)O)(C)C)OC(=O)C)O)[C@@H](C)O,C47H68O17,231.1,91.6
Tributyrin,CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC,C15H26O6,76.8,30.5
Hydrazine,NN,H4N2,9.1,3.6
2’-Deoxycytidine,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O,C9H13N3O4,51.8,20.5
Marizomib,C[C@]12[C@H](C(=O)N[C@]1(C(=O)O2)[C@H]([C@H]3CCCC=C3)O)CCCl,C15H20ClNO4,76.4,30.3
Verbascoside,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H](O[C@@H]([C@H]2OC(=O)/C=C/C3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O,C29H36O15,148.4,58.8
Hexestrol,CC[C@H](C1=CC=C(C=C1)O)[C@@H](CC)C2=CC=C(C=C2)O,C18H22O2,82.6,32.7
Ascorbyl palmitate,CCCCCCCCCCCCCCCC(=O)OC[C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O,C22H38O7,109.6,43.5
Senecionine,C/C=C\1/C[C@H]([C@@](C(=O)OCC2=CCN3[C@H]2[C@@H](CC3)OC1=O)(C)O)C,C18H25NO5,87.7,34.8
Streptonigrin,CC1=C(C(=C(N=C1C(=O)O)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)N)OC)N)C4=C(C(=C(C=C4)OC)OC)O,C25H22N4O8,126.7,50.2
Epothilone A,C[C@H]1CCC[C@@H]2[C@@H](O2)C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C,C26H39NO6S,133.8,53
Valinomycin,C[C@H]1C(=O)N[C@H](C(=O)O[C@@H](C(=O)N[C@@H](C(=O)O[C@H](C(=O)N[C@H](C(=O)O[C@@H](C(=O)N[C@@H](C(=O)O[C@H](C(=O)N[C@H](C(=O)O[C@@H](C(=O)N[C@@H](C(=O)O1)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C,C54H90N6O18,280.9,111.3
Trifluralin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-],C13H16F3N3O4,77.2,30.6
Tanshinone IIA,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C,C19H18O3,81.9,32.5
"3,4-Dihydroxybenzoic acid",C1=CC(=C(C=C1C(=O)O)O)O,C7H6O4,36.9,14.6
Oryzalin,CCCN(CCC)C1=C(C=C(C=C1[N+](=O)[O-])S(=O)(=O)N)[N+](=O)[O-],C12H18N4O6S,82.9,32.9
Diallyl disulfide,C=CCSSCC=C,C6H10S2,45.3,18
Ethyl methanesulfonate,CCOS(=O)(=O)C,C3H8O3S,26.5,10.5
Idarubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,C26H27NO9,123.6,49
Valrubicin,CCCCC(=O)OCC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(=O)C(F)(F)F)O,C34H36F3NO13,164.8,65.3
Afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,C24H25ClFN5O3,131.2,52
Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,C21H19ClN4O4,112,44.4
Formestane,C[C@]12CCC(=O)C(=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,C19H26O3,83,32.9
Fadrozole,C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N,C14H13N3,68.3,27.1
Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,C24H29N7O2,123.9,49.1
Fedratinib,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,C27H36N6O3S,146,57.9
Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,C23H20F3N5O2S2,127.4,50.5
Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,C28H24FN3O5,137,54.3
Duvelisib,C[C@@H](C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,C22H17ClN6O,116,46
Ruxolitinib,C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C17H18N6,88.8,35.2
Decitabine,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O,C8H12N4O4,50.2,19.9
Belinostat,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO,C15H14N2O4S,83,32.9
Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,C27H32F2N8,140.4,55.6
Trilostane,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C,C20H27NO3,88.6,35.1
Encorafenib,C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC,C22H27ClFN7O4S,134.1,53.2
Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,C30H34N4O2,140.4,55.7
Capmatinib,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,C23H17FN6O,115.6,45.8
Tivozanib,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,C22H19ClN4O5,120.9,47.9
Quizartinib,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,C29H32N6O4S,153.8,61
Carmofur,CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,C11H16FN3O3,62.3,24.7
Pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,C20H21N5O6,106.3,42.1
Tepotinib,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,C29H28N6O2,144.5,57.3
Lonidamine,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,C15H10Cl2N2O2,81.9,32.5
Panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO,C21H23,106.7,42.3
Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,C29H39ClN7O2P,160.1,63.5
Niraparib,C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,C19H20N4,92.7,36.8
Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,C28H36ClN5O3S,151.5,60.1
Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,C28H33N7O2,146.6,58.1
Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,C45H50ClN7O7S,234.4,92.9
Talazoparib,CN1C(=NC=N1)[C@@H]2[C@H](NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,C19H14F2N6O,97,38.5
Lomustine,C1CCC(CC1)NC(=O)N(CCCl)N=O,C9H16ClN3O2,57.8,22.9
Ibrutinib,C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,C25H24N6O2,126.1,50
Sotorasib,C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,C30H30F2N6O3,150.5,59.6
Gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,C29H44N8O3,157.8,62.5
Pacritinib,C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,C28H32N4O3,135.1,53.6
Larotrectinib,C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F,C21H22F2N6O2,109.1,43.2
Selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,C29H31N7O3,147.5,58.5
Alocrest,CCC1=CC2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,C45H54N4O8,214.2,84.9
Nilutamide,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,C12H10F3N3O4,66.3,26.3
Entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,C31H34F2N6O2,156.6,62.1
Lorlatinib,C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,C21H19FN6O2,108.5,43
Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,C16H17N7O2S,98.2,38.9
Acalabrutinib,CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,C26H23N7O2,133.2,52.8
Geldanamycin,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)/C)OC)OC(=O)N)\C)C)O)OC,C29H20N2O9,146.8,58.2
Asciminib,C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,C20H18ClF2N5O3,109.7,43.5
Selinexor,C1=CN=C(C=N1)NNC(=O)/C=C\N2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,C17H11F6N7O,96.7,38.3
Triaziquone,C1CN1C2=CC(=O)C(=C(C2=O)N3CC3)N4CC4,C12H13N3O2,59.6,23.6
Belzutifan,CS(=O)(=O)C1=C2[C@@H]([C@@H]([C@@H](C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,C17H12F3NO4S,84.9,33.6
Carfilzomib,CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,C40H57N5O7,197.5,78.3
Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,C25H30N6O2,129.6,51.4
Imiquimod,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,C14H16N4,71,28.2
Fumagillin,CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)OC)C,C26H34O7,124.3,49.3
Tirbanibulin,C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4,C26H29N3O3,124.2,49.2
Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,C28H28O3,122.6,48.6
Bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,C30H34N2O3,138.9,55.1
Pirtobrutinib,C[C@@H](C(F)(F)F)N1C(=C(C(=N1)C2=CC=C(C=C2)CNC(=O)C3=C(C=CC(=C3)F)OC)C(=O)N)N,C22H21F4N5O3,112.9,44.8
Olutasidenib,C[C@@H](C1=CC2=C(C=CC(=C2)Cl)NC1=O)NC3=CC=C(N(C3=O)C)C#N,C18H15ClN4O2,93.4,37
Temsirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,C56H87NO16,273.2,108.3
Anagrelide,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3,C10H7Cl2N3O,61.1,24.2
Fludarabine Phosphate,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)F)N,C10H13FN5O7P,69.8,27.7
Elacestrant,CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)[C@@H]3CCC4=C(C3)C=CC(=C4)O,C30H38N2O2,141.9,56.2
Goserelin,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,C59H84N18O14,323.7,128.3
Dimethyl Fumarate,COC(=O)/C=C/C(=O)OC,C6H8O4,33.5,13.3
Leuprolide,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,C59H84N16O12,316,125.3
Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,C21H16F4N4O2S,110.3,43.7
Apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,C21H15F4N5O2S,110.7,43.9
Triethylenemelamine,C1CN1C2=NC(=NC(=N2)N3CC3)N4CC4,C9H12N6,53.5,21.2
Cinobufagin,CC(=O)O[C@@H]1[C@@H]([C@]2(CC[C@H]3[C@H]([C@@]24[C@@H]1O4)CC[C@H]5[C@@]3(CC[C@@H](C5)O)C)C)C6=COC(=O)C=C6,C26H34O6,116.6,46.2
Halofuginone,C1C[C@H]([C@@H](NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O,C16H17BrClN3O3,93.4,37
Cinoxacin,CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3,C12H10N2O5,62.4,24.7
Pidotimod,C1CC(=O)N[C@@H]1C(=O)N2CSC[C@H]2C(=O)O,C9H12N2O4S,56.2,22.3
Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,C6H8ClN7O,49.9,19.8
Honokiol,C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C,C18H18O2,82.4,32.7
Pazufloxacin,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)N)F)C(=O)O,C16H15FN2O4,77.7,30.8
Brivudine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br)CO)O,C11H13BrN2O5,70,27.7
Dihydrodiethylstilbestrol,CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O,C18H22O2,82.6,32.7
Nitroarginine,C(C[C@@H](C(=O)O)N)CN=C(N)N[N+](=O)[O-],C6H13N5O4,47.5,18.8
Fleroxacin,CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F,C17H18F3N3O3,85.8,34
Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,C28H54N8,151.5,60.1
Gemifloxacin,CO/N=C/1\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,C18H20FN5O4,94.9,37.6
10-Hydroxycamptothecin,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O,C20H16N2O5,95,37.7
Buthionine sulfoximine,CCCCS(=N)(=O)CCC(C(=O)O)N,C8H18N2O3S,53.7,21.3
Degarelix,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=C(C=C2)NC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)NC(=O)[C@@H]4CC(=O)NC(=O)N4)NC(=O)[C@H](CO)NC(=O)[C@@H](CC5=CN=CC=C5)NC(=O)[C@@H](CC6=CC=C(C=C6)Cl)NC(=O)[C@@H](CC7=CC8=CC=CC=C8C=C7)NC(=O)C,C82H103ClN18O16,432.8,171.6
Sparfloxacin,C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,C19H22F2N4O3,96.9,38.4
Chlorotrianisene,COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC,C23H21ClO3,110.2,43.7
trichostatin A,C[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C,C17H22N2O3,88.1,34.9
Trifluridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,C10H11F3N2O5,55.9,22.2
Teriflunomide,C/C(=C(\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O,C12H9F3N2O2,60.6,24
Octreotide,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O,C49H66N10O10S2,273.9,108.6
Lanreotide,C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)N)O,C54H69N11O10S2,298.3,118.3
Apremilast,CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,C22H24N2O7S,115.9,45.9
Acridine,C1=CC=C2C(=C1)C=C3C=CC=CC3=N2,C13H9N,60,23.8
Hydroxyflutamide,CC(C)(C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F)O,C11H11F3N2O4,62.8,24.9
Ginsenoside Rg3,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O)C,C42H72O13,204.4,81
Cyproterone,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)O,C22H27ClO3,99.6,39.5
Silibinin B,COC1=C(C=CC(=C1)[C@H]2[C@@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,C25H22O10,120,47.6
Triethylenephosphoramide,C1CN1P(=O)(N2CC2)N3CC3,C6H12N3OP,42.1,16.7
Ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N,C23H24N4O3,110.7,43.9
Relugolix,CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC,C29H27F2N7O5S,158.2,62.7
4-Ipomeanol,CC(CCC(=O)C1=COC=C1)O,C9H12O3,44,17.4
Puromycin,CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](CC4=CC=C(C=C4)OC)N)O,C22H29N7O5,120.6,47.8
Swainsonine,C1C[C@H]([C@@H]2[C@@H]([C@@H](CN2C1)O)O)O,C8H15NO3,43.4,17.2
Biochanin A,COC1=CC=C(C=C1)C2=COC3=CC(=CC(=C3C2=O)O)O,C16H12O5,74.6,29.6
Juglone,C1=CC2=C(C(=O)C=CC2=O)C(=C1)O,C10H6O3,44.8,17.8
(-)-Epicatechin gallate,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,C22H18O10,106.9,42.4
Thiodiglycol,C(CSCCO)O,C4H10O2S,31.6,12.5
Helenalin,C[C@@H]1C[C@@H]2[C@H]([C@@H]([C@]3([C@H]1C=CC3=O)C)O)C(=C)C(=O)O2,C15H18O4,68.2,27
Aziridine,C1CN1,C2H5N,12.6,5
Cytochalasin E,C[C@H]1C/C=C/[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@]2(C(=O)N[C@H]4CC5=CC=CC=C5)OC(=O)O/C=C/[C@@](C1=O)(C)O)C)C,C28H33NO7,130.9,51.9
Aclarubicin,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O,C42H53NO15,202.6,80.3
Infigratinib,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,C26H31Cl2N7O3,151.6,60.1
Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,C17H15BrClFN4O3,101.3,40.2
Estramustine,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl,C23H31Cl2NO3,116.3,46.1
Trofosfamide,C1CN(P(=O)(OC1)N(CCCl)CCCl)CCCl,C9H18Cl3N2O2,72.4,28.7
Entinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,C21H20N4O3,107.2,42.5
Alpelisib,CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,C19H22F3N5O2S,106.7,42.3
Binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,C17H15BrF2N4O3,96.6,38.3
Enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,C19H17F6N7O,105.6,41.9
Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,C19H18FN3O,91.9,36.4
Ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,C23H30N8O,123.4,48.9
Futibatinib,COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)[C@H]4CCN(C4)C(=O)C=C)OC,C22H22N6O3,115.8,45.9
Veliparib,C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,C13H16N4O,70.2,27.8
Avapritinib,C[C@](C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,C26H27FN10,140.1,55.5
Fenretinide,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)NC2=CC=C(C=C2)O)/C)/C,C26H33NO2,125.1,49.6
Ixazomib,B([C@H](CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,C14H19BCl2N2O4,87.5,34.7
Ivosidenib,C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,C28H22ClF3N6O3,140.1,55.5
Glasdegib,CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,C21H22N6O,106.9,42.4
Semustine,CC1CCC(CC1)NC(=O)N(CCCl)N=O,C10H18ClN3O2,62.3,24.7
Dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4,C24H25ClFN5O2,129.5,51.3
Midostaurin,C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,C35H30N4O4,160.3,63.5
Vindesine,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O,C43H55N5O7,208.4,82.6
Sonidegib,C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,C26H26F3N3O3,126.7,50.2
Ripretinib,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,C24H21BrFN5O2,129.7,51.4
Fotemustine,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,C9H19ClN3O5P,70.3,27.9
Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,C24H27F2N5O4,125.1,49.6
Ipatasertib,C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O,C24H32ClN5O2,125.4,49.7
Cobimetinib,C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,C21H21F3IN3O2,115.3,45.7
Pexidartinib,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,C20H15ClF3N5,106.1,42.1
Ethoglucid,C1C(O1)COCCOCCOCCOCC2CO2,C12H22O6,63.8,25.3
Capivasertib,C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,C21H25ClN6O2,116,46
Adagrasib,CN1CCC[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F,C32H35ClFN7O2,163.4,64.8
Zanubrutinib,C=CC(=O)N1CCC(CC1)[C@@H]2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,C27H29N5O3,133.1,52.8
Ensartinib,C[C@@H]1CN(C[C@@H](N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)O[C@H](C)C4=C(C=CC(=C4Cl)F)Cl)N,C26H27Cl2FN6O3,145,57.5
Hypericin,CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)C)O)O)O,C30H16O8,142.6,56.5
Ixabepilone,C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C,C27H42N2O5S,140.1,55.5
Lasofoxifene,C1CCN(C1)CCOC2=CC=C(C=C2)[C@H]3[C@H](CCC4=C3C=CC(=C4)O)C5=CC=CC=C5,C28H31NO2,125.1,49.6
Filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,C21H23N5O3S,114.3,45.3
Treosulfan,CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,C6H14O8S2,54,21.4
Momelotinib,C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N,C23H22N6O2,116.4,46.1
Temoporfin,C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O,C44H32N4O4,196.9,78
Idronoxil,C1C(=CC2=C(O1)C=C(C=C2)O)C3=CC=C(C=C3)O,C15H12O3,67.8,26.9
Eribulin,C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O,C40H59NO11,188.5,74.7
Trifarotene,CC(C)(C)C1=C(C=CC(=C1)C2=C(C=CC(=C2)C3=CC=C(C=C3)C(=O)O)OCCO)N4CCCC4,C29H33NO4,188.5,53
Oltipraz,CC1=C(SSC1=S)C2=NC=CN=C2,C8H6N2S3,61.4,24.4
Lurbinectedin,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O,C41H44N4O10S,205.6,81.5
Semaxanib,CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C,C15H14N2O,72,28.6
Alvocidib,CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,C21H20ClNO5,104,41.2
Brequinar,CC1=C(C2=C(C=CC(=C2)F)N=C1C3=CC=C(C=C3)C4=CC=CC=C4F)C(=O)O,C23H15F2NO2,103.1,40.9
Epothilone D,C[C@H]1CCC/C(=C\C[C@H](OC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C2=CSC(=N2)C)/C)/C,C27H41NO5S,138.4,54.9
Megestrol,CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,C22H30O3,96.8,38.4
Piritrexim,CC1=C2C(=NC(=NC2=NC=C1CC3=C(C=CC(=C3)OC)OC)N)N,C44H19N5O2,94.3,37.4
O-(chloroacetylcarbamoyl)fumagillol,CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)NC(=O)CCl)OC)C,C19H28ClNO6,99.2,39.3
Diethylstilbestrol Diphosphate,CC/C(=C(/CC)\C1=CC=C(C=C1)OP(=O)(O)O)/C2=CC=C(C=C2)OP(=O)(O)O,C18H22O8P2,103.4,41
Grapiprant,CCC1=NC2=C(N1C3=CC=C(C=C3)CCNC(=O)NS(=O)(=O)C4=CC=C(C=C4)C)C=C(N=C2C)C,C26H29N5O3S,138.2,54.8
Dexanabinol,CCCCCCC(C)(C)C1=CC(=C2[C@H]3CC(=CC[C@@H]3C(OC2=C1)(C)C)CO)O,C25H38O3,115.1,45.6
Dolastatin 10,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C,C42H68N6O6S,219.6,87.1
Lomefloxacin,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,C17H19F2N3O3,85.4,33.9
Troglitazone,CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C,C24H27NO5S,120.5,47.8
Pefloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,C17H20FN3O3,85.6,33.9
Rufloxacin,CN1CCN(CC1)C2=C(C=C3C4=C2SCCN4C=C(C3=O)C(=O)O)F,C17H18FN3O3S,92.8,36.8
Dienogest,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O,C20H25NO2,87.2,34.6
Tipifarnib,CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,C27H22Cl2N4O,137.3,54.4
Nadifloxacin,CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2N4CCC(CC4)O)F)C(=O)O,C19H21FN2O4,91.6,36.3
Prulifloxacin,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C,C21H20FN3O6S,112.1,44.4
Cepharanthine,CN1CCC2=CC3=C(C4=C2[C@@H]1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)C[C@@H]7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,C37H38N2O6,170.9,67.8
Tilorone,CCN(CC)CCOC1=CC2=C(C=C1)C3=C(C2=O)C=C(C=C3)OCCN(CC)CC,C25H34N2O3,121.1,48
Histrelin,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8,C66H86N18O12,350.5,139
Cridanimod,C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3N2CC(=O)O,C15H11NO3,68.4,27.1
Trovafloxacin,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,C20H15F3N4O3,96.8,38.4
Abiraterone,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O,C24H31NO,105.2,41.7
Grepafloxacin,CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F,C19H22FN3O3,92.8,36.8
Xanthohumol,CC(=CCC1=C(C(=C(C=C1O)OC)C(=O)/C=C/C2=CC=C(C=C2)O)O)C,C21H22O5,102.8,40.7
Abarelix,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C,C72H95ClN14O14,377,149.5
Licochalcone a,CC(C)(C=C)C1=C(C=C(C(=C1)/C=C/C(=O)C2=CC=C(C=C2)O)OC)O,C21H22O4,100.3,39.8
Voclosporin,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,C63H111N11O12,333.2,132.1
"3,3’-Diindolylmethane",C1=CC=C2C(=C1)C(=CN2)CC3=CNC4=CC=CC=C43,C21H14N2,80.1,31.8
Polidocanol,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,C30H62O10,158.3,62.7
Dodecafluoropentane,C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F,C5F12,27,10.7
5-Fluoro-2’-deoxycytidine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)N)F)CO)O,C9H12FN3O4,51.7,20.5
Abiraterone Acetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,C26H33NO2,144.8,45.5
Maxacalcitol,C[C@@H]([C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)OCCC(C)(C)O,C26H42O4,121.5,48.2
Letermovir,COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,C29H28F4N4O4,142.5,56.5
Perflubron,C(C(C(C(C(F)(F)Br)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F,C8BrF17,49.4,19.6
Cholesterol sulfate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C)C,C27H46O4S,130.5,51.7
Clascoterone,CCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)CO,C24H34O5,108.3,42.9
Upadacitinib,CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F,C17H19F3N6O,91.6,36.3
Siponimod,CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O,C29H35F3N2O3,135.9,53.9
Calphostin,C CC(CC1=C2C3=C(C(=C(C4=C3C(=C5C2=C(C(=O)C=C5OC)C(=C1OC)O)C(=CC4=O)OC)O)OC)CC(C)OC(=O)OC6=CC=C(C=C6)O)OC(=O)C7=CC=CC=C7,C44H38O14,206.6,81.9
Amygdalin,C1=CC=C(C=C1)[C@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O,C20H27NO11,104.9,41.6
Nocodazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CS3,C14H11N3O3S,80.8,32
Ellipticine,CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)C,C17H14N2,82,32.5
Cyclofenil,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C,C23H24O4,104,41.2
Sarsasapogenin,C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@H]6[C@@]5(CC[C@@H](C6)O)C)C)C)OC1,C27H44O3,119.7,47.4
Wortmannin,CC(=O)O[C@@H]1C[C@]2([C@@H](CCC2=O)C3=C1[C@]4([C@H](OC(=O)C5=COC(=C54)C3=O)COC)C)C,C23H24O8,104.1,41.3
Combretastatin A4,COC1=C(C=C(C=C1)/C=C\C2=CC(=C(C(=C2)OC)OC)OC)O,C18H20O5,92.2,36.6
Tubercidin,C1=CN(C2=NC=NC(=C21)N)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,C11H14N4O4,61.5,24.4
Norcantharidin,C1CC2C3C(C1O2)C(=O)OC3=O,C8H8O4,36.5,14.5
6(5H)-Phenanthridinone,C1=CC=C2C(=C1)C3=CC=CC=C3NC2=O,C13H9NO,57.3,22.7
Hinokitiol,CC(C)C1=CC(=O)C(=CC=C1)O,C10H12O2,46.7,18.5
6-Aminonicotinamide,C1=CC(=NC=C1C(=O)N)N,C6H7N3O,37.5,14.9
Purine Nucleosides,C1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,C10H12N4O4,58,23
"5,8-Dihydroxy-1,4-naphthoquinone",C1=CC(=C2C(=O)C=CC(=O)C2=C1O)O,C10H6O4,46.7,18.5
Bufalin,C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4C5=COC(=O)C=C5)O)C)O,C24H34O4,106.9,42.4
Phenyl acetate,CC(=O)OC1=CC=CC=C1,C8H8O2,37.6,14.9
N-Nitroso-N-methylurea,CN(C(=O)N)N=O,C2H5N3O2,22.2,8.8
Dactolisib,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,C30H23N5O,140.4,55.7
Pirarubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O[C@@H]6CCCCO6,C32H37NO12,154.6,61.3
Amonafide,CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,C16H17N3O2,82,32.5
Etoposide Phosphate,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)OP(=O)(O)O)OC)O)O,C29H33O16P,150.1,59.5
Pelitinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C,C24H23ClFN5O2,126.3,50.1
Rociletinib,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,C27H28F3N7O3,144.4,57.3
Tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,C26H24N8O2,135.2,53.6
Roscovitine,CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,C19H26N6O,102,40.4
Vinflunine,CC[C@@]12C=CCN3[C@@H]1[C@]4(CC3)[C@H]([C@]([C@@H]2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)[C@]6(C[C@@H]7C[C@H](CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C,C45H54F2N4O8,214.8,85.2
Parsaclisib,CCOC1=C(C(=C(C=C1[C@H](C)N2C3=NC=NC(=C3C(=N2)C)N)Cl)F)[C@H]4CC(=O)NC4,C20H22ClFN6O2,108.8,43.1
Cediranib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,C25H27FN4O3,126.5,50.1
beta-Lapachone,CC1(CCC2=C(O1)C3=CC=CC=C3C(=O)C2=O)C,C15H14O3,65.8,26.1
Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,C34H44N4O4,166,65.8
Mobocertinib,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,C32H39N7O4,166.9,66.2
Aumolertinib,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC,C30H35N7O2,153.5,60.8
9-Aminocamptothecin,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5N=C4C3=C2)N)O,C20H17N3O4,97.1,38.5
Pixantrone,C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN,C17H19N5O2,92.3,36.6
Lazertinib,CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,C30H34N8O3,158.1,62.7
Olmutinib,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4,C26H26N6O2S,141.6,56.1
Tiazofurin,C1=C(N=C(S1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,C9H12N2O5S,59.3,23.5
Inavolisib,C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F,C18H19F2N5O4,95.3,37.8
Pamiparib,C[C@]12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,C16H15FN4O,77.7,30.8
Vinburnine,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,C19H22N2O,86.5,34.3
Fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,C21H19N3O5,108.7,43.1
Navitoclax,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,C47H55ClF3N5O6S3,252.3,100
Vorasidenib,C[C@H](C(F)(F)F)NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)N[C@H](C)C(F)(F)F,C14H13ClF6N6,86.7,34.4
Mitobronitol,C([C@H]([C@H]([C@@H]([C@@H](CBr)O)O)O)O)Br,C6H12Br2O4,51.3,20.3
Ospemifene,C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\C3=CC=C(C=C3)OCCO)/CCCl,C24H23ClO2,112.3,44.5
Tamibarotene,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,C22H25NO3,103.2,40.9
Imidazole carboxamide,CN(C)/N=N/C1=C(NC=N1)C(=O)N,C6H10N6O,46.2,18.3
Arzoxifene,COC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)OC4=CC=C(C=C4)OCCN5CCCCC5,C28H29NO4S,138,54.7
Alvespimycin,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)/C)OC)OC(=O)N)\C)C)O)OC,C32H48N4O8,166.4,66
Salirasib,CC(=CCC/C(=C/CC/C(=C/CSC1=CC=CC=C1C(=O)O)/C)/C)C,C22H30O2S,109.5,43.4
Foretinib,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,C34H34F2N4O6,167.9,66.5
Tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65,C23H19N3O2,105,41.6
Pevonedistat,C1CC2=CC=CC=C2[C@H]1NC3=C4C=CN(C4=NC=N3)[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N,C21H25N5O4S,113.6,45
Volasertib,CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,C34H50N8O3,174.7,69.3
Etanidazole,C1=CN(C(=N1)[N+](=O)[O-])CC(=O)NCCO,C7H10N4O4,49.7,19.7
Doxifluridine,C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O,C9H11FN2O5,51.9,20.6
Suramin,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C,C51H40N6O23S6,302.4,119.9
Triptorelin,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8,C64H82N18O13,340.3,134.9
Tacedinaline,CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N,C15H15N3O2,79.3,31.5
Misonidazole,COCC(CN1C=CN=C1[N+](=O)[O-])O,C7H11N3O4,47,18.6
Masitinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,C28H30N6OS,147.4,58.4
Tirapazamine,C1=CC=C2C(=C1)[N+](=C(N=[N+]2[O-])N)[O-],C7H6N4O2,44.3,17.6
Metildigoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)OC,C42H66O14,201.2,79.8
Givinostat,CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO,C24H27N3O4,122.3,48.5
Asiaticoside,C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(C[C@H]([C@@H]([C@@]5(C)CO)O)O)C)C)[C@@H]2[C@H]1C)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O)O)O)O,C48H78O19,236.2,93.6
Carboxyamidotriazole,C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2Cl)CN3C(=C(N=N3)C(=O)N)N)Cl)Cl,C17H12Cl3N5O2,102.6,40.7
Lometrexol,C1[C@H](CNC2=C1C(=O)NC(=N2)N)CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,C21H25N5O6,110.9,44
Irofulven,CC1=C(C2=C(C3(CC3)[C@@](C(=O)C2=C1)(C)O)C)CO,C15H18O3,67.2,26.6
Leniolisib,CCC(=O)N1CC[C@@H](C1)NC2=NC=NC3=C2CN(CC3)C4=CC(=C(N=C4)OC)C(F)(F)F,C21H25F3N6O2,111.2,44.1
Idasanutlin,CC(C)(C)C[C@H]1[C@]([C@H]([C@@H](N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,C31H29Cl2F2N3O4,154.9,61.4
Coformycin,C1[C@H](C2=C(NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O,C11H16N4O5,63.5,25.2
Terameprocol,C[C@H](CC1=CC(=C(C=C1)OC)OC)[C@@H](C)CC2=CC(=C(C=C2)OC)OC,C22H30O4,105.5,41.8
Darolutamide,C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,C19H19ClN6O2,106.5,42.2
Ixazomib Citrate,B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,C20H23BCl2N2O9,117.1,46.4
Mizoribine,C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N,C9H13N3O6,53.5,21.2
Falnidamol,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl,C18H19ClFN7,105,41.6
Pirlindole,CC1=CC2=C(C=C1)N3CCNC4C3=C2CCC4,C15H18N2,68.3,27.1
PK 11195,CCC(C)N(C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl,C21H21ClN2O,103.9,41.2
o6-Benzylguanine,C1=CC=C(C=C1)COC2=NC(=NC3=C2NC=N3)N,C12H11N5O,68.2,27
Doramapimod,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,C31H37N5O3,153.2,60.7